Layegh, Z.; Hooijberg, F.; Boekel, L.; Looijen, A.E.M.; van Mulligen, E.; Loeff, F.C.; Dijk, L.; Dolhain, R.J.E.M.; Rispens, T.; Wolbink, G.J.;
et al. The Association Between Serum Drug Concentration and a Flare in Rheumatoid Arthritis Patients Tapering TNF Inhibitors. Pharmaceuticals 2025, 18, 1506.
https://doi.org/10.3390/ph18101506
AMA Style
Layegh Z, Hooijberg F, Boekel L, Looijen AEM, van Mulligen E, Loeff FC, Dijk L, Dolhain RJEM, Rispens T, Wolbink GJ,
et al. The Association Between Serum Drug Concentration and a Flare in Rheumatoid Arthritis Patients Tapering TNF Inhibitors. Pharmaceuticals. 2025; 18(10):1506.
https://doi.org/10.3390/ph18101506
Chicago/Turabian Style
Layegh, Zohra, Femke Hooijberg, Laura Boekel, Agnes E. M. Looijen, Elise van Mulligen, Floris C. Loeff, Lisanne Dijk, Radboud J. E. M. Dolhain, Theo Rispens, Gertjan J. Wolbink,
and et al. 2025. "The Association Between Serum Drug Concentration and a Flare in Rheumatoid Arthritis Patients Tapering TNF Inhibitors" Pharmaceuticals 18, no. 10: 1506.
https://doi.org/10.3390/ph18101506
APA Style
Layegh, Z., Hooijberg, F., Boekel, L., Looijen, A. E. M., van Mulligen, E., Loeff, F. C., Dijk, L., Dolhain, R. J. E. M., Rispens, T., Wolbink, G. J., & de Jong, P. H. P.
(2025). The Association Between Serum Drug Concentration and a Flare in Rheumatoid Arthritis Patients Tapering TNF Inhibitors. Pharmaceuticals, 18(10), 1506.
https://doi.org/10.3390/ph18101506